First Financial Bank Trust Division Gilead Sciences, Inc. Transaction History
First Financial Bank Trust Division
- $1.01 Billion
- Q2 2024
A detailed history of First Financial Bank Trust Division transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Financial Bank Trust Division holds 79,485 shares of GILD stock, worth $5.77 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
79,485
Previous 93,309
14.82%
Holding current value
$5.77 Million
Previous $6.83 Million
20.21%
% of portfolio
0.54%
Previous 0.66%
Shares
26 transactions
Others Institutions Holding GILD
# of Institutions
1,892Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.89 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$8.32 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$6.13 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.44 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$4.19 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $90.9B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...